| Quarterly Financials | Jun 2024 | Sept 2024 | Jun 2025 | Sept 2025 |
Revenue  | 6 | 3 | 3 | 10 |
| Expenses | 4 | 2 | 3 | 7 |
| EBITDA | 2 | 1 | 0 | 3 |
| Operating Profit % | 23 % | 23 % | 1 % | 27 % |
| Depreciation | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 1 |
| Profit Before Tax | 1 | 1 | -0 | 2 |
| Tax | 0 | 0 | 0 | 1 |
| Net Profit | 1 | 0 | -0 | 1 |
| EPS in ₹ | 1.21 | 0.57 | -0.17 | 1.15 |
Auro Laboratories
Auro Laboratories
257.05
-9.90
(-3.71%)
Market Cap
160.23 Cr
PE Ratio
90.49
Volume
278.00
Day High - Low
266.95 - 255.05
52W High-Low
317.00 - 159.00
Key Fundamentals
Market Cap
160.23 Cr
EPS
5.67
PE Ratio
90.49
PB Ratio
3.87
Book Value
74.37
EBITDA
9.86
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
4.28
Debt to Equity
0.81
Actual
Company News
View All News
Mr. Kuntal Pancholi resigned as CFO of Auro Laboratories Limited effective May 28, 2026, due to personal reasons.
Auro Laboratories board meets on May 29
9 days ago
9 days agoAuro Laboratories Limited board will meet on May 29, 2026, to consider audited financial results for FY26. Trading window closed from April 1.
Auro Laboratories Limited receives ACUITE BB+ stable rating for Rs.64.20 crore long-term facilities and ACUITE A4+ for Rs.15.60 crore short-term facilities from Acuite Ratings.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,788.50 | #1 4,29,121.06 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.37 | |
6,576.50 | 1,74,585.41 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 46.75 | |
4,368.50 | 1,47,849.89 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 50.11 | |
1,375.20 | 1,11,086.00 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 52.65 | |
1,076.60 | 1,08,331.15 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 68.91 | |
1,263.30 | 1,05,440.45 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 41.47 | |
2,261.20 | 1,03,346.61 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 45.17 | |
2,369.50 | 97,814.16 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 50.42 | |
1,440.40 | 83,658.67 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 48.90 | |
1,394.30 | 75,272.20 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 76.00 |
Growth Rate
Revenue Growth
52.94 %
Net Income Growth
167.22 %
Cash Flow Change
-69.43 %
ROE
-76.95 %
ROCE
-78.64 %
EBITDA Margin (Avg.)
48.76 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 29 | 26 | 27 | 30 | 34 | 32 | 42 | 55 | 56 | 86 | 99 | 121 |
| Fixed Assets | 10 | 9 | 13 | 13 | 15 | 14 | 14 | 14 | 13 | 22 | 21 | 90 |
| Current Assets | 18 | 12 | 14 | 16 | 19 | 18 | 28 | 38 | 36 | 31 | 22 | 31 |
| Capital Work in Progress | 1 | 3 | 0 | 1 | 0 | 0 | 0 | 4 | 8 | 33 | 57 | 15 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 |
| Other Assets | 18 | 13 | 14 | 16 | 19 | 18 | 28 | 38 | 36 | 31 | 22 | 0 |
| Total Equity & Liabilities | 29 | 26 | 27 | 30 | 34 | 32 | 42 | 55 | 56 | 86 | 99 | 121 |
| Current Liabilities | 14 | 10 | 6 | 7 | 7 | 6 | 9 | 20 | 18 | 24 | 22 | 29 |
| Non Current Liabilities | 8 | 7 | 11 | 11 | 10 | 5 | 4 | 3 | 4 | 20 | 35 | 46 |
| Total Equity | 8 | 9 | 9 | 13 | 17 | 22 | 29 | 32 | 34 | 42 | 43 | 46 |
| Reserve & Surplus | 2 | 2 | 3 | 7 | 11 | 15 | 22 | 25 | 28 | 36 | 37 | 40 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 0 | 1 | 1 | 2 | 2 | 9 | -2 | -10 | -1 | -1 |
| Investing Activities | -1 | -2 | -2 | -3 | -3 | -2 | -4 | -5 | -5 | -39 | -25 |
| Operating Activities | -1 | 8 | 7 | 6 | 7 | 9 | 13 | -7 | 3 | 19 | 6 |
| Financing Activities | 1 | -5 | -4 | -2 | -2 | -6 | -1 | 10 | -8 | 19 | 18 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 51.92 % | 51.92 % | 51.93 % | 51.99 % | 51.99 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.15 % | 52.15 % | 52.15 % | 52.15 % | 52.18 % | 52.18 % | 52.18 % | 52.18 % | 52.18 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 37.66 % | 36.94 % | 39.57 % | 39.57 % | 40.17 % | 40.12 % | 37.34 % | 39.82 % | 39.87 % | 37.58 % | 36.23 % | 35.56 % | 35.03 % | 35.33 % | 35.42 % | 36.15 % | 36.57 % | 36.42 % | 36.35 % | 36.26 % | 36.28 % |
| Others | 10.41 % | 11.14 % | 8.50 % | 8.43 % | 7.83 % | 7.78 % | 10.57 % | 8.08 % | 8.03 % | 10.32 % | 11.68 % | 12.34 % | 12.81 % | 12.52 % | 12.43 % | 11.69 % | 11.25 % | 11.40 % | 11.47 % | 11.56 % | 11.54 % |
| No of Share Holders | 9,151 | 9,377 | 10,129 | 10,189 | 11,340 | 11,362 | 11,183 | 11,135 | 10,906 | 10,501 | 10,272 | 9,905 | 9,441 | 9,335 | 9,266 | 9,265 | 9,102 | 8,916 | 8,860 | 8,640 | 8,405 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Jun 2024 |  Annual General Meeting | NA | 28 Jun 2024 | 235.15 | 203.00 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 246.25 | 245.70 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 230.35 | 224.80 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 256.20 | 256.35 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 268.45 | 258.00 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 247.35 | 240.60 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 195.50 | 190.70 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 207.20 | 253.95 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 269.90 | 272.30 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
2 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in Management5 days ago
5 days agoResults For The Year Ended March 31 20265 days ago
5 days agoBoard Meeting Outcome for Held On May 29 20265 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)6 days ago
6 days agoBoard Meeting Intimation for Board Meeting To Be Held On May 29 20269 days ago
9 days agoReceipt Of Certification Of Substances Department From European Directorate For The Quality Of Medicines & Healthcare (EDQM)May 05, 2026
May 05, 2026Receipt Of Certificate Of GMP Compliance Of A Manufacturer From Swissmedic Swiss Agency For Therapeutic Products.May 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Credit RatingApr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Apr 14, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Feb 07, 2026Financial Results For The Quarter Ended December 31 2025Feb 05, 2026
Feb 05, 2026Board Meeting Outcome for Outcome Of The Board MeetingFeb 05, 2026
Feb 05, 2026Board Meeting Intimation for Unaudited Financial Results For Quarter Ended December 31 2025.Jan 28, 2026
Jan 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2026
Jan 14, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Nov 14, 2025Grant Of Certificate Of Good Manufacturing Practices From World Health Organisation (WHQ").Nov 12, 2025
Nov 12, 2025Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Outcome Of The Board Meeting Dated November 12 2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for Unaudited Financial Results Of The Company For Quarter And Half Year Ended September 30 2025.Nov 06, 2025
Nov 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Sep 09, 2025 Regulation 36(1)(B) Of SEBI (LODR) RegulationsSep 03, 2025
Sep 03, 2025Reg. 34 (1) Annual Report.Sep 03, 2025
Sep 03, 2025Notice Of 36Th Annual General Meeting (AGM) Scheduled On Thursday September 25 2025Sep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Sep 02, 2025Appointment of Company Secretary and Compliance OfficerAug 23, 2025
Aug 23, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated August 23 2025Aug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerAug 14, 2025
Aug 14, 2025 Un-Audited Financial Results For The Quarter Ended June 30 2025.Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On August 14 2025.Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2025.Aug 07, 2025
Aug 07, 2025Disclosure Under Regulation 30Jul 09, 2025
Jul 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Jul 04, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 11, 2025
Jun 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2025
Jun 02, 2025Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 31, 2025
May 31, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
May 30, 2025Technical Indicators
RSI(14)
Neutral 50.52
ATR(14)
Less Volatile 14.53
STOCH(9,6)
Neutral 58.49
STOCH RSI(14)
Neutral 50.18
MACD(12,26)
Bullish 0.47
ADX(14)
Weak Trend 22.22
UO(9)
Bearish 55.06
ROC(12)
Downtrend And Accelerating -0.39
WillR(14)
Neutral -56.48
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
